Pages that link to "Q71586107"

The following pages link to Both anti-CD11a (LFA-1) and anti-CD11b (MAC-1) therapy delay the onset and diminish the severity of experimental autoimmune encephalomyelitis (Q71586107):

Displaying 48 items.

• Leukocyte integrins: role in leukocyte recruitment and as therapeutic targets in inflammatory disease (Q26822941) (← links)
• Inflammatory monocytes and the pathogenesis of viral encephalitis (Q26861256) (← links)
• Adhesion molecules and matrix metalloproteinases in Multiple Sclerosis: effects induced by Interferon-beta. (Q30817229) (← links)
• Macrophages inhibit neovascularization in a murine model of age-related macular degeneration (Q33253660) (← links)
• Tolerability, pharmacokinetics and pharmacodynamics of CMAB001, an anti-CD11a antibody, in Chinese healthy volunteers and psoriatic patients (Q33571293) (← links)
• Binding of recombinant T cell receptor ligands (RTL) to antigen presenting cells prevents upregulation of CD11b and inhibits T cell activation and transfer of experimental autoimmune encephalomyelitis. (Q34077153) (← links)
• Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease (Q34112417) (← links)
• MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α-PU.1 pathway. (Q34606028) (← links)
• Complement depletion reduces macrophage infiltration and activation during Wallerian degeneration and axonal regeneration (Q34751192) (← links)
• Beneficial effect of chronic Staphylococcus aureus infection in a model of multiple sclerosis is mediated through the secretion of extracellular adherence protein (Q35066772) (← links)
• Three or more routes for leukocyte migration into the central nervous system (Q35183162) (← links)
• Monoclonal antibody therapy in experimental allergic encephalomyelitis and multiple sclerosis (Q35208773) (← links)
• beta2-integrins in demyelinating disease: not adhering to the paradigm (Q35539301) (← links)
• Persistent macrophage/microglial activation and myelin disruption after experimental autoimmune encephalomyelitis in tissue inhibitor of metalloproteinase-1-deficient mice (Q35569899) (← links)
• Antigen‐specific blocking of CD4‐Specific immunological synapse formation using BPI and current therapies for autoimmune diseases (Q35637379) (← links)
• p150/95 (CD11c/CD18) expression is required for the development of experimental autoimmune encephalomyelitis (Q35855614) (← links)
• What do we know about the mechanism of action of disease-modifying treatments in MS? (Q35953300) (← links)
• The complement system plays a critical role in the development of experimental autoimmune anterior uveitis (Q35989062) (← links)
• Systemic immunomodulation of autoimmune disease using MHC-derived recombinant TCR ligands (Q36107636) (← links)
• Suppression of experimental autoimmune encephalomyelitis by extracellular adherence protein of Staphylococcus aureus (Q36228518) (← links)
• Regulation of interleukin-12 by complement receptor 3 signaling (Q36377284) (← links)
• Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment (Q36385159) (← links)
• Treatment with anti-LFA-1 delays the CD8+ cytotoxic-T-lymphocyte response and viral clearance in mice with primary respiratory syncytial virus infection (Q36510050) (← links)
• Targeting integrin structure and function in disease (Q36580090) (← links)
• Structural modifications of ICAM-1 cyclic peptides to improve the activity to inhibit heterotypic adhesion of T cells (Q36844463) (← links)
• Brain-peripheral cell crosstalk in white matter damage and repair (Q38414220) (← links)
• Monoclonal Antibodies in Preclinical EAE Models of Multiple Sclerosis: A Systematic Review (Q41660408) (← links)
• Immunological Treatment of Autoimmune Diseases (Q41722148) (← links)
• Effector and suppressor roles for LFA-1 during the development of experimental autoimmune encephalomyelitis (Q41951909) (← links)
• Disruption of the beta2-integrin CD11d (alphaDbeta2) gene fails to protect against experimental autoimmune encephalomyelitis (Q42094299) (← links)
• Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis (Q43760330) (← links)
• Effect of therapeutic integrin (CD11a) blockade with efalizumab on immune responses to model antigens in humans: results of a randomized, single blind study (Q44951728) (← links)
• A role for alpha4-integrin in the pathology following Semliki Forest virus infection (Q45742408) (← links)
• Therapy with antibody against leukocyte integrin VLA-4 (CD49d) is effective and safe in virus-facilitated experimental allergic encephalomyelitis (Q45765166) (← links)
• Haptoglobin deficiency facilitates the development of autoimmune inflammation. (Q48445330) (← links)
• Differential activation of microglia in neurogenic versus non-neurogenic regions of the forebrain (Q48464342) (← links)
• Interferon-beta directly influences monocyte infiltration into the central nervous system. (Q48589403) (← links)
• Long-term impact of neonatal inflammation on demyelination and remyelination in the central nervous system (Q48726467) (← links)
• Macrophage phagocytosis of myelin in vitro determined by flow cytometry: phagocytosis is mediated by CR3 and induces production of tumor necrosis factor-alpha and nitric oxide (Q48882573) (← links)
• Progesterone attenuates demyelination and microglial reaction in the lysolecithin-injured spinal cord (Q50436940) (← links)
• LFA-1 expression on CD4(+)CD45RO(+) peripheral blood T-lymphocytes in RR MS: effects induced by rIFNbeta-1a (Q52019189) (← links)
• Reduced Treg frequency in LFA-1-deficient mice allows enhanced T effector differentiation and pathology in EAE. (Q52900254) (← links)
• Blockade of CD11a by Efalizumab in Psoriasis Patients Induces a Unique State of T-Cell Hyporesponsiveness (Q60683093) (← links)
• Multiple sclerosis: trapped in deadly glue (Q61853106) (← links)
• Psoriasis treatment (Q61962806) (← links)
• 1,25-dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis (Q73497706) (← links)
• [Update on pathophysiologic and immunotherapeutic approaches for the treatment of multiple sclerosis] (Q80434989) (← links)
• Extracellular adherence protein of Staphylococcus aureus suppresses disease by inhibiting T-cell recruitment in a mouse model of psoriasis (Q84667076) (← links)